| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_066d3975286268497e9eb8fcd396a0ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 |
| filingDate |
1988-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7af3d898a47ec811c36bf418d99e7327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_074720fba3985e5313772b2c47b9e470
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7c6c4b19a331508957e1a45d6c672b9 |
| publicationDate |
1990-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-3828582-A1 |
| titleOfInvention |
MONOCLONAL ANTIBODY TO INHIBIT THE INFECTION OF CELLS BY HIV VIRUSES |
| abstract |
The monoclonal antibody 30F16H5T4-MK, which can be obtained from the hybridoma cell line ECACC 88050502, is used to inhibit the infection by HIV and SIV viruses of cells with a CD4-protein on their surface. A drug for preventing infection by HIV viruses and/or the spreading of viruses in the body after infection contains the monoclonal antibody 30F16H5, optionally with the usual pharmaceutical carrier substances and additives. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3919294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3919294-C2 |
| priorityDate |
1988-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |